Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. 詳細を表示
BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively...
BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...
BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...
Daniel Baker, M.D., will join Cue Biopharma’s executive team as interim chief development officer (CDO), effective Monday, November 25, 2024Anish Suri, Ph.D., president & chief scientific...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.15 | 12.6050420168 | 1.19 | 1.495 | 1.111 | 411669 | 1.35506452 | CS |
| 4 | 0.25 | 22.9357798165 | 1.09 | 1.75 | 1.02 | 441377 | 1.40864451 | CS |
| 12 | -0.42 | -23.8636363636 | 1.76 | 1.9891 | 0.92 | 460432 | 1.30200139 | CS |
| 26 | 0.6749 | 101.473462637 | 0.6651 | 1.9891 | 0.45 | 589535 | 1.17060193 | CS |
| 52 | -1.37 | -50.5535055351 | 2.71 | 2.82 | 0.45 | 444526 | 1.33478521 | CS |
| 156 | -5.89 | -81.4661134163 | 7.23 | 8.01 | 0.45 | 356015 | 2.71979178 | CS |
| 260 | -14.88 | -91.738594328 | 16.22 | 35.5 | 0.45 | 340635 | 7.55529249 | CS |
boston127
3週前
Hawkeye_tt
3週前
boston127
3週前
boston127
3週前
boston127
3週前
Hawkeye_tt
3週前
boston127
3週前
Hawkeye_tt
4週前
glenn1919
4週前
Hawkeye_tt
4月前
boston127
4月前
boston127
4月前
boston127
4月前
boston127
4月前
Monksdream
4月前
Hawkeye_tt
4月前
Triple nickle
4月前
Hawkeye_tt
4月前
Monksdream
7月前
Hawkeye_tt
2年前
conix
3年前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
